ELVN logo

Enliven Therapeutics, Inc. (ELVN) Net Income

Annual Net Income:

-$89.02M-$17.44M(-24.36%)
December 31, 2024

Summary

  • As of today, ELVN annual net profit is -$89.02 million, with the most recent change of -$17.44 million (-24.36%) on December 31, 2024.
  • During the last 3 years, ELVN annual net income has fallen by -$64.28 million (-259.84%).
  • ELVN annual net income is now -6082.80% below its all-time high of $1.49 million, reached on December 31, 2022.

Performance

ELVN Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNincome statement metrics

Quarterly Net Income:

-$20.15M+$5.19M(+20.47%)
September 30, 2025

Summary

  • As of today, ELVN quarterly net profit is -$20.15 million, with the most recent change of +$5.19 million (+20.47%) on September 30, 2025.
  • Over the past year, ELVN quarterly net income has increased by +$3.01 million (+12.99%).
  • ELVN quarterly net income is now -162.60% below its all-time high of $32.19 million, reached on December 31, 2022.

Performance

ELVN Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNincome statement metrics

TTM Net Income:

-$97.21M+$3.01M(+3.00%)
September 30, 2025

Summary

  • As of today, ELVN TTM net profit is -$97.21 million, with the most recent change of +$3.01 million (+3.00%) on September 30, 2025.
  • Over the past year, ELVN TTM net income has dropped by -$11.99 million (-14.07%).
  • ELVN TTM net income is now -2486.62% below its all-time high of $4.07 million, reached on December 31, 2022.

Performance

ELVN TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

ELVN Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-24.4%+13.0%-14.1%
3Y3 Years-259.8%-90.9%-129.1%
5Y5 Years-279.4%-62.2%-225.7%

ELVN Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-6082.8%at low-162.6%+29.4%-2486.6%+3.0%
5Y5-Year-6082.8%at low-162.6%+29.4%-2486.6%+3.0%
All-TimeAll-Time-6082.8%at low-162.6%+29.4%-2486.6%+3.0%

ELVN Net Income History

DateAnnualQuarterlyTTM
Sep 2025
-
-$20.15M(+20.5%)
-$97.21M(+3.0%)
Jun 2025
-
-$25.34M(+11.2%)
-$100.22M(-5.7%)
Mar 2025
-
-$28.54M(-23.1%)
-$94.83M(-6.5%)
Dec 2024
-$89.02M(-24.4%)
-$23.18M(-0.1%)
-$89.02M(-4.5%)
Sep 2024
-
-$23.16M(-16.1%)
-$85.21M(-2.9%)
Jun 2024
-
-$19.95M(+12.3%)
-$82.83M(-4.1%)
Mar 2024
-
-$22.74M(-17.4%)
-$79.60M(-11.2%)
Dec 2023
-$71.58M(-4910.8%)
-$19.37M(+6.7%)
-$71.58M(-257.4%)
Sep 2023
-
-$20.77M(-24.2%)
-$20.03M(-104.1%)
Jun 2023
-
-$16.72M(-13.6%)
-$9.81M(-395.2%)
Mar 2023
-
-$14.72M(-145.7%)
-$1.98M(-148.7%)
Dec 2022
$1.49M
$32.19M(+405.0%)
$4.07M(+109.6%)
Sep 2022
-
-$10.55M(-18.7%)
-$42.43M(+6.8%)
Jun 2022
-
-$8.89M(-2.5%)
-$45.52M(+8.6%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$8.67M(+39.5%)
-$49.80M(+3.1%)
Dec 2021
-$24.74M(+40.2%)
-
-
Dec 2021
-
-$14.32M(-4.9%)
-$51.38M(-5.8%)
Sep 2021
-
-$13.65M(-3.7%)
-$48.58M(-2.6%)
Jun 2021
-
-$13.16M(-28.3%)
-$47.36M(-6.7%)
Mar 2021
-
-$10.26M(+10.9%)
-$44.40M(-7.4%)
Dec 2020
-$41.36M(-76.3%)
-$11.52M(+7.3%)
-$41.36M(-38.6%)
Sep 2020
-
-$12.42M(-21.7%)
-$29.84M(-24.1%)
Jun 2020
-
-$10.20M(-41.4%)
-$24.04M(-73.7%)
Mar 2020
-
-$7.21M(-9.0%)
-$13.84M(-109.0%)
Dec 2019
-$23.46M(-107.0%)
-
-
Sep 2019
-
-$6.62M
-$6.62M
Dec 2018
-$11.34M(-5229.9%)
-
-
Dec 2017
$221.00K
-
-

FAQ

  • What is Enliven Therapeutics, Inc. annual net profit?
  • What is the all-time high annual net income for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. annual net income year-on-year change?
  • What is Enliven Therapeutics, Inc. quarterly net profit?
  • What is the all-time high quarterly net income for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. quarterly net income year-on-year change?
  • What is Enliven Therapeutics, Inc. TTM net profit?
  • What is the all-time high TTM net income for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. TTM net income year-on-year change?

What is Enliven Therapeutics, Inc. annual net profit?

The current annual net income of ELVN is -$89.02M

What is the all-time high annual net income for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high annual net profit is $1.49M

What is Enliven Therapeutics, Inc. annual net income year-on-year change?

Over the past year, ELVN annual net profit has changed by -$17.44M (-24.36%)

What is Enliven Therapeutics, Inc. quarterly net profit?

The current quarterly net income of ELVN is -$20.15M

What is the all-time high quarterly net income for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high quarterly net profit is $32.19M

What is Enliven Therapeutics, Inc. quarterly net income year-on-year change?

Over the past year, ELVN quarterly net profit has changed by +$3.01M (+12.99%)

What is Enliven Therapeutics, Inc. TTM net profit?

The current TTM net income of ELVN is -$97.21M

What is the all-time high TTM net income for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high TTM net profit is $4.07M

What is Enliven Therapeutics, Inc. TTM net income year-on-year change?

Over the past year, ELVN TTM net profit has changed by -$11.99M (-14.07%)
On this page